© 2021 MJH Life Sciences and AJMC. All rights reserved.
© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
October 24th 2021, 1:00am
The issue of systemic lupus erythematosus (SLE) is particularly important in Asia, because patients there suffer from more severe disease and damage compared with patients in Western countries.
October 14th 2021, 5:00pm
An international group of researchers devised updated guidelines on the management and treatment of cutaneous lupus erythematosus (CLE).
October 1st 2021, 11:00am
A new study suggests the lower-cost, more patient-friendly assessment method may be a useful tool for clinicians.
September 27th 2021, 5:00pm
This new study adds to the literature by giving the first long-term data in these populations.
September 25th 2021, 2:00pm
A minority of patients will experience flares, but in most cases reintroduction of therapy will result in remission.
September 23rd 2021, 8:10pm
Intravenous belimumab had benefits, but also resulted in more health care utilization due to the nature of its administration.
September 17th 2021, 12:00pm
Treat-to-target has long been used in adults, but a new study finds it is warranted in pediatric cases, too.
September 15th 2021, 5:00pm
Five case reports suggested the anti-BAFF monoclonal antibody was effective at reducing disease activity scores for adults who have neuropsychiatric systemic lupus erythematosus (NPSLE).
September 8th 2021, 8:15pm
A case report details the presentation of systemic lupus erythematous in a young, previously healthy individual.
September 1st 2021, 5:10pm
Patients with systemic lupus erythematosus (SLE) said they still suffered significant pain and fatigue, even though they reported high rates of satisfaction with their therapies.